The much-anticipated results of TauRx's Phase III trial for Alzheimer's disease have finally been disclosed. Despite some complicated effects, this could be…
Biogen and AbbVie have been granted EU marketing authorization for Zinbryta (daclizumab), to treat adult patients with relapsing forms of multiple sclerosis.…